- Using Ascletis' proprietary Ultra-Long-Acting Platform technology, co-formulation of ASC36, a once-monthly subcutaneously administered amylin receptor peptide agonist and ASC35, a once-monthly subcutaneously administered GLP-1R/GIPR dual peptide agonist, demonstrated a comparable pharmacokinetic (PK) profile to ASC36 and ASC35 dosed alone in head-to-head non-human primate studies. - ASC36 monotherapy demonstrated approximately 32% greater relative body weight reduction compared to eloralintide monotherapy in a head-to-head diet-induced obese (DIO) rat study, while ASC35 monotherapy
BRISBANE, Australia, Nov. 13, 2025 -- Laronix, ("Laronix" or the "Company"), a commercial-stage medical technology (MedTech) company and an industry-leading innovator in voice restoration technologies, today announced that it has been awarded AUD $3.2 million (approximately USD $2.1 million) in non-dilutive funding from the Australian Government's Industry Growth Program (IGP 2025). Farzaneh Ahmadi, PhD, Chief Executive Officer of Laronix, said, "Human voice loss is a largely unattended global health problem afflicting millions of patients every year. L
SHANGHAI, Nov. 12, 2025 -- The leading electric vertical take-off and landing (eVTOL) firm, TCab Tech, has announced the completion of its RMB 300 million (approx. USD 43 million) Series B++ funding round, jointly invested by Meridian Capital, HuaHan Capital, and Puhua Capital. This is TCab Tech's second funding round completed in 2025 and the seventh since its founding, bringing the company's total funding to over RMB 1 billion (approx. USD 143 million). This funding marks the first major investment in China's low-altitude economy sector since the industry was designated as a
CAPE CORAL, Fla., Nov. 13, 2025 -- Starwood Pet Travel, a global leader in international pet relocation, has reported an 800% increase in relocations since 2019, driven in part by a surge of doctors, nurses, and other medical professionals moving to New Zealand with their pets. According to the Medical Council of New Zealand, internationally trained doctors currently make up more than 43% of New Zealand's medical workforce, and over 70% of all new doctor registrations in the year ending June 2024 were overseas-trained. For nursing, the Nursing Council of New Zealand repo
세계적 수준의 Empower™ 크로마토그래피 데이터 시스템(CDS)과 원활하게 통합되어 품질 관리 및 개발 환경의 효율성과 신뢰성을 향상시킵니다. 멀티벤더 LC-CAD 구성에서 최대 70%까지 발생하는 CDS 통신 오류를 완화합니다.[1] 광범위한 분석대상 화합물 전체에 거의 보편적으로 검출을 가능하게 하며, UV 또는 질량 분석법으로 측정하기 어려운 물질을 포함하여 제약 제형, 식품 첨가물 및 환경 오염 물질의 광범위한 분석 물질에 대해 거의 보편적인 검출 기능을 제공합니다. 매사추세츠주 밀퍼드, 2025년 11월 12일 -- Waters Corporation (NYSE:WAT)은 오늘, 세계적으로 가장 신뢰받는 크로마토그래피 데이터 시스템(CDS)인 Waters Empower 소프트웨어와의 완벽한 호환을 위해 설계된 하전 에어로졸 검출기(Charged Aerosol Detector, CAD)를 새롭게 출시했다고 발표했습니다. Waters는 규제 당국에 크로마토그래피 소프트웨어 솔루션의 글로벌 시장 리더이며, Empower 소프트웨어는 전체 신약의 약 80%에 대한 데이터를 규제 기관에 제출하는 데 사용됩니다.[
CAPE TOWN, South Africa, Nov. 11, 2025 -- MGI Tech Co., Ltd., a company dedicated to developing core tools and technologies that drive innovation in life sciences, today announced two historic milestones in African genomics: the official unveiling of the continent's first DNBSEQ-T7 sequencing platform at the South African Medical Research Council (SAMRC), and the signing of a Memorandum of Understanding (MoU) between MGI, the Department of Science, Technology and Innovation (DSTI), and the SAMRC to launch the 110K Human Genome Program in South Africa. These milestones represent a trans
NEW DELHI, Nov. 11, 2025 -- To observe this year's Breast Cancer Awareness Month, Apollo Cancer Centres (ACCs) recently launched across India a unique initiative that blended indulgence with awareness through 'Check-Olate', a sweet treat that carries an even sweeter reminder: take a moment for yourself. Breast cancer is one of the major public health challenges worldwide. GLOBOCAN data indicates approximately 2.3 million new female breast cancer cases worldwide. Recognising the urgent need for greater awareness and proactive prevention, ACCs aimed to normalise self-care
HONG KONG, Nov. 11, 2025 -- On 8 November, Guo Guangchang, Chairman of Fosun International, attended the 3rd Pujiang Biopharmaceutical Original Innovation Conference 2025. During the conference, Guo Guangchang stated, "At this crucial juncture today, China's pharmaceutical innovation is gaining increasing attention and recognition around the world. More than ever, we are convinced that original innovation is the only way forward for the industry, and open cooperation is the best way to accelerate innovation." With the theme of "Original Innovation, the Future of Intellig
-The live telesurgery took place during the XLVI Annual Congress of the Chilean Society of Urology, which also marked the Society's 100th anniversary. This procedure highlights how network connectivity is enabling new forms of surgical collaboration. SINGAPORE, Nov. 11, 2025 -- During the 46th Annual Congress of the Chilean Society of Urology held in Santiago, Dr. Marcelo Kerbebe, successfully performed a telesurgery using OMNIBOT, Reach Surgical's robotic-assisted system. Operating remotely from the congress venue, Dr. Kerbebe used the OMNIBOT console to p
SINGAPORE, Nov. 11, 2025 -- In recognition of Diabetes Awareness Month, NOVI Health is honoured to launch "It Starts with One: Taking Charge This World Diabetes Month", a campaign dedicated to raising awareness, promoting healthy living, and supporting the diabetes community in Singapore. As part of the campaign, NOVI Health will host a series of events and educational initiatives aimed at empowering individuals to take charge of their metabolic health. Educational Webinar: "Thriving with Diabetes at Work and Beyond" The highlight of the campaign is a